Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM

Conditions: Multiple Myeloma in Relapse Interventions: Drug: Pomalidomide, cyclophosphamide combined with dexametha Sponsors: Shanxi Bethune Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials